Title : Oregovomab: an investigational agent for the treatment of advanced ovarian cancer.

Pub. Date : 2021 Feb

PMID : 33423551






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Despite novel compound classes like vascular endothelial growth factor (VEGF) inhibitors or poly-ADP ribose polymerase (PARP) inhibitors are available, which improve significantly efficacy of platinum-based chemotherapy, OC prognosis remains poor and innovative strategies are needed. Platinum poly(ADP-ribose) polymerase 1 Homo sapiens
2 Despite novel compound classes like vascular endothelial growth factor (VEGF) inhibitors or poly-ADP ribose polymerase (PARP) inhibitors are available, which improve significantly efficacy of platinum-based chemotherapy, OC prognosis remains poor and innovative strategies are needed. Platinum poly(ADP-ribose) polymerase 1 Homo sapiens